|
| Sweeping Changes Ahead for Biotech, Says Ernst & Young
| | June 11, 2008 | The global biotechnology industry achieved record levels in financing and deal making in 2007, as investors and strategic partners showed strong confidence in the sector amid tightening global financial conditions that will continue to test the industry in 2008. |
|
|
|
| FDA Approves Expanded Adjuvant Indications for Herceptin
| | May 23, 2008 | US Food and Drug Administration's Division of Biologic Oncology Products has approved two new biologics license application (BLA) supplements expanding the approval of Genentech's Herceptin (trastuzumab) for the treatment of breast cancer. |
|